Traders Buy Large Volume of Put Options on SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the target of unusually large options trading on Friday. Stock traders acquired 57,114 put options on the company. This represents an increase of approximately 43% compared to the typical daily volume of 40,006 put options.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Bank of America Corp DE grew its position in shares of SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after acquiring an additional 1,700,851 shares in the last quarter. Hsbc Holdings PLC increased its stake in shares of SPDR S&P Biotech ETF by 7.8% during the 4th quarter. Hsbc Holdings PLC now owns 638,529 shares of the exchange traded fund’s stock worth $78,049,000 after purchasing an additional 46,339 shares during the last quarter. Main Street Research LLC lifted its position in SPDR S&P Biotech ETF by 57.4% during the 1st quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock worth $72,484,000 after acquiring an additional 206,953 shares during the last quarter. Strs Ohio lifted its holdings in shares of SPDR S&P Biotech ETF by 4.9% during the 1st quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock worth $52,433,000 after acquiring an additional 19,300 shares during the period. Finally, SG Americas Securities LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 41.4% in the 1st quarter. SG Americas Securities LLC now owns 391,243 shares of the exchange traded fund’s stock worth $49,973,000 after acquiring an additional 114,638 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 3.8%

Shares of XBI stock traded down $5.64 during trading hours on Friday, hitting $144.14. The company’s stock had a trading volume of 9,441,197 shares, compared to its average volume of 9,171,963. The stock has a market cap of $9.89 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The business has a fifty day moving average of $158.35 and a 200-day moving average of $146.89. SPDR S&P Biotech ETF has a twelve month low of $106.30 and a twelve month high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.